International neuroblastoma staging system stage 1 neuroblastoma: A prospective study and literature review

Journal of Clinical Oncology

Volumn 14, Issue 7, 1996, Pages 2174-2180

  Kushner, B H ^a   Cheung, N K ^a   LaQuaglia, M P ^a   Ambros, P F ^a   Ambros, I M ^a   Bonilla, M A ^a   Ladanyi, M ^a   Gerald, W L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; DACARBAZINE; VINCRISTINE;

ADULT; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW;

EID: 0029947799     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.7.2174     Document Type: Review

References (55)

1. Bader KL, Miller RW: US cancer incidence and mortality in the first year of life. Am J Dis Child 133:157-159, 1979
2. Miller RW, Young JL, Novakovic B: Childhood Cancer. Cancer 75:395-405, 1995
3. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985
4. Look AT, Hayes FA, Shuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: A Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991
5. Caron H: Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavorable prognostic markers in neuroblastoma. Med Pediatr Oncol 24:215-221, 1995
6. Evans AE, D'Angio GJ, Propert K, et al: Prognostic factors in neuroblastoma. Cancer 59:1853-1859, 1987
7. Shuster JJ, McWilliams NB, Castleberry R, et al: Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study. Am J Clin Oncol 15:295-303, 1992
8. Zeltzer PM, Marangos PJ, Evans AE, et al: Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 57:1230-1234, 1986
9. Shimada H, Chatten J, Newton WA Jr, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
10. Joshi VJ, Cantor AB, Altschuler G, et al: Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69:2197-2211, 1992
11. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Cancer 27:374-378, 1971
12. Hayes FA, Green A, Hustu HO, et al: Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastases. J Pediatr 102:59-62, 1983
13. Nitschke R, Smith EI, Shochat S, et al: Localized neuroblastoma treated by surgery: A Pediatric Oncology Group study. J Clin Oneol 6:1271-1279, 1988
14. Brodeur GM, Pritchard J, Berthold F, et al: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
15. Kushner BH, LaQuaglia MP, Bonilla MA, et al: Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 12:2607-2613, 1994
16. Kushner BH, Cheung NKV, LaQuaglia MP, et al: Survival from locally invasive or metastatic neuroblastoma without cytotoxic therapy. J Clin Oncol 14:373-381, 1996
17. Kohl N, Kanda N, Schreck R, et al: Transposition and amplification of oncogene-related sequences in human neuroblastoma. Cell 35:359-367, 1983
18. Heiden T, Wang N, Tribukait B: An improved Hedley method for preparation of paraffin-embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 12:614-621, 1991
19. Stock C, Ambros IM, Mann G, et al: Detection of 1p36 deletions in paraffin sections of neuroblastoma tissues. Genes Chromosomes Cancer 6:1-9, 1993
20. Evans AE, Albo V, D'Angio GJ, et al: Cyclophosphamide treatment of patients with localized and regional neuroblastoma. A randomized study. Cancer 38:655-660, 1976
21. Evans AE, Brand W, de Lorimier A, et al: Results in children with local and regional neuroblastoma managed with and without vincristine, Cyclophosphamide, and imidazole-carboxamide. A report from the Children's Cancer Study Group. Am J Clin Oncol 6:3-8, 1984
22. Berthold F, Brandeis WE, Lampert F: Neuroblastoma: Diagnostic advances and therapeutic results in 370 patients. Monogr Paediatr 18:206-223, 1986
23. De Bernardi B, Rogers D, Carli M, et al: Localized neuroblastoma. Surgical and pathologic staging. Cancer 60:1066-1072, 1987
24. De Bernardi B, Conte M, Mancini A, et al: Localized resectable neuroblastoma: Results of the second study of the Italian Cooperative Group for Neuroblastoma. J Clin Oncol 13:884-893, 1995
25. Castleberry RP, Crist WM, Cain WS, et al: Management of localized thoracic neuroblastoma. Med Pediatr Oncol 7:153-161, 1979
26. Adam A, Hochholzer L: Ganglioneuroblastoma of the posterior mediastinum: A clinicopathologic review of 80 cases. Cancer 47:373-381, 1981
27. Evans AE, D'Angio GJ, Koop CE: The role of multimodal therapy in patients with local and regional neuroblastoma. J Pediatr Surg 19:77-80, 1984
28. Haase CM, Atkinson JB, Stram DO, et al: Surgical management and outcome of locoregional neuroblastoma: Comparison of the Childens Cancer Group and the International staging systems. J Pediatr Surg 30:289-295, 1995
29. Kaneko Y, Kanda N, Maseki N, et al: Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: A chromosome and N-myc amplification study. J Clin Oncol 8:2005-2013, 1990
30. Nakagawara A, Zaizen Y, Ikeda K, et al: Different genomic and metabolic patterns between mass screening-positive and mass-screening-negative later-presenting neuroblastomas. Cancer 68:2037-2044, 1991
31. Hayashi Y, Hanada R, Yamamota K: Biology of neuroblastomas in Japan found by screening. Am J Pediatr Hematol Oncol 14:342-347, 1992
32. Hachitanda Y, Ishimoto K, Hata J, et al: One hundred neuroblastomas detected through a mass screening system in Japan. Cancer 74:3223-3226, 1994
33. Evans AE, Albo V, D'Angio GJ, et al: Factors influencing survival of children with nonmetastatic neuroblastoma. Cancer 38:661-666, 1976
34. Ninane J, Pritchard J, Morris Jones PH, et al: Stage II neuroblastoma. Adverse prognostic significance of lymph node involvement. Arch Dis Child 57:438-442, 1982
35. Rosen EM, Cassady JR, Kretschmar C, et al: Influence of local-regional lymph node metastases on prognosis in neuroblastoma. Med Pediatr Oncol 12:260-263, 1984
36. McGuire WA, Simmons D, Grosfeld JL, et al: Stage II neuroblastoma-Does adjuvant irradiation contribute to cure? Med Pediatr Oncol 13:117-121, 1985
37. Matthay KK, Sather HN, Seeger RC, et al: Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7:236-244, 1989
38. Nitschke R, Humphrey GB, Sexauer CL, et al: Neuroblastoma: therapy for infants with good prognosis. Med Pediatr Oncol 11:154-158, 1983
39. Carachi R, Campbell PE, Kent M: Thoracic neural crest tumors. A clinical review. Cancer 51:949-954, 1983
40. Matthay KK, Stram D, Seeger RC, et al: A prospective Childrens Cancer Group study of stage II neuroblastoma treated with surgery alone. Proc Am Soc Clin Oncol 12:414, 1993 (abstr)
41. Haase GM, Wong KY, deLorimier AA, et al: Improvement in survival after excision of primary tumor in stage III neuroblastoma. J Pediatr Surg 24:194-200, 1989
42. Tsuchida Y, Yokoyama J, Kaneko, et al: Therapeutic significance of surgery in advanced neuroblastoma: A report from the Study Group of Japan. J Pediatr Surg 27:616-622, 1992
43. West DC, Shamberger RC, Macklis RM, et al: Stage III neuroblastoma over 1 year of age at diagnosis: Improved survival with intensive multimodality therapy including multiple alkylating agents. J Clin Oncol 11:84-90, 1993
44. Castel V, Badal MD, Bezanilla JL, et al: Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: A report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Med Pediatr Oncol 24:29-35, 1995
45. Le Tourneau JN, Bernard JL, Hendren WH, et al: Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediatr Surg 20:244-249, 1985
46. Garaventa A, De Bernardi B, Pianca C, et al: Localized but unresectable neuroblastoma: Treatment and outcome of 145 cases. J Clin Oncol 11:1770-1779, 1993
47. Shamberger RC, Allarde-Segundo A, Kozakewich HPW, et al: Surgical management of stage III and IV neuroblastoma: Resection before or after chemotherapy? J Pediatr Surg 26:1113-1118, 1991
48. Rubie H, Plantaz D, Michon J, et al: Localized neuroblastoma: N-myc gene amplification is the main prognostic factor and postoperative treatment can be deleted in infants. Med Pediatr Oncol 21:582, 1993 (abstr)
49. Fabbretti G, Valenti C, Loda M, et al: N-myc gene amplification/expression in localized stroma-rich neuroblastoma (ganglioneuroblastoma). Hum Pathol 24:294-297, 1993
50. Cohn SL, Look AT, Joshi VV, et al: Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: A Pediatric Oncology Group study. Cancer Res 55:721-726, 1995
51. Evans AE: Staging and treatment of neuroblastoma. Cancer 45:1799-1802, 1980
52. Murphy SB, Cohn SL, Craft AW, et al: Do children benefit from mass screening for neuroblastoma? Consensus statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet 337:344-346, 1991
53. Goodman SN: Neuroblastoma screening data. An epidemiologic analysis. Am J Dis Child 145:1415-1422, 1991
54. Matthay K, Seeger R, Haase G, et al: Treatment and outcome for stage III neuroblastoma based on prospective biologic staging. Med Pediatr Oncol 23:173, 1994 (abstr)
55. Castleberry R, Shuster JJ, Altschuler G, et al: Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: A Pediatric Oncology Group study. J Clin Oncol 10:1299-1304, 1992